The 6 W’s: Who, what, where, when, why and what of it … Read more…
Patients who suffer from a severe form of refractory (untreatable) heart failure … Read more…
Expressed in Cell Therapy in Separate Studies … Read more…
A visual Read more…
A challenge to FDA’s Medical Device Authority …? Read more…
Government contract to support national preparedness Read more…
For Celution(R) System Read more…
Net loss was $7.9M or $0.13 per share Read more…
Cytori (CYTX) Q2/12 Investor conference call results on 8/8/12 Read more…
To launch product line for plastic surgery and select soft tissue therapies Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.